Back to Search
Start Over
Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia.
- Source :
-
Acta anaesthesiologica Scandinavica [Acta Anaesthesiol Scand] 2004 Sep; Vol. 48 (8), pp. 1019-27. - Publication Year :
- 2004
-
Abstract
- Background: The diagnosis of susceptibility to malignant hyperthermia (MH) is currently performed on muscle biopsies subjected to halothane-caffeine in vitro contracture tests (IVCTs). There is a consensus on our need to improve the diagnostic potential of IVCTs if we are to maximize the information available for research and diagnosis in MH. This study was designed as a pilot comparative study and we aimed at comparing the ryanodine test and new tests using a combination of ryanodine, halothane and caffeine.<br />Methods: One hundred and thirty-two subjects (52 MHS and 80 MHN) were included in this study and new IVCTs were performed in additional muscle biopsy specimens. The contracture time-course was compared considering the onset time of contracture (OT) and the time to reach a 10 mN contracture (10T). Cut-off values were determined using ROC analyses.<br />Results: For the ryanodine test, sensitivity and specificity calculated for OT were 84.6% and 90.4%, respectively, and were better than those obtained using 10T. Combined tests using either caffeine and ryanodine or halothane and ryanodine did provide higher sensitivities (from 85.3 to 93.9%). A better specificity was only observed for the IVC tests combining halothane (cumulated) and caffeine both with ryanodine (93.9% for both). The largest sensitivity was observed when halothane was used as a bolus and combined with ryanodine. The specificity was always larger with the combined tests as compared to the test using ryanodine alone (from 79.1 to 90.9%). This superiority was confirmed, at least in part, when comparing genetic investigations and the results of new tests in a subgroup of subjects.<br />Conclusions: This pilot study showed a clear diagnostic potential for new IVC tests combining halothane, the triggering agent of MH, and ryanodine acting at the calcium release channel, and should be considered as a first step in the investigation of combined tests.
- Subjects :
- DNA genetics
Humans
In Vitro Techniques
Malignant Hyperthermia genetics
Malignant Hyperthermia physiopathology
Muscle Contraction drug effects
Mutation genetics
Predictive Value of Tests
ROC Curve
Reverse Transcriptase Polymerase Chain Reaction
Anesthetics, Inhalation
Caffeine
Halothane
Malignant Hyperthermia diagnosis
Muscle, Skeletal drug effects
Phosphodiesterase Inhibitors
Ryanodine
Subjects
Details
- Language :
- English
- ISSN :
- 0001-5172
- Volume :
- 48
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Acta anaesthesiologica Scandinavica
- Publication Type :
- Academic Journal
- Accession number :
- 15315621
- Full Text :
- https://doi.org/10.1111/j.0001-5172.2004.00461.x